Chicago-based GE HealthCare designed its AI-enabled auto-contouring software to assist radiation oncology teams with treatment planning. It aims to reduce treatment planning time, enabling more focus on delivering timely, personalized care.

FDA clearance includes a Predetermined Change Control Plan (PCCP) as well, the company said in a news release. This establishes a framework for introducing future model updates and enhancements. GE HealthCare expects this to help enable the expansion of models across additional anatomical regions and imaging modalities.